BACKGROUND: We determined fetal sex in pregnancies referred for invasive prenatal diagnosis procedures by analysis of DNA in maternal plasma. METHODS: Twelve pregnancies at risk of X-linked haemophilia and 32 pregnancies at risk of chromosomal aneuploidies at a gestational age ranging from 10 to 18 weeks recruited before chorionic villus sampling or amniocentesis were involved in the study. Male fetal DNA in maternal plasma was detected by using real-time polymerase chain reaction with the SRY gene as a marker. RESULTS: The specificity of the system reached 100% (no Y signal was detected in 17 women pregnant with a female fetus) and the sensitivity reached 100% (SRY amplification in 27 examined samples). CONCLUSIONS: Amplification of free fetal DNA in maternal plasma is a valid and rapid technique for predicting fetal sex in first- and second-trimester pregnancies and could allow the restriction of invasive sampling procedures to male fetuses at risk of X-linked disorders. Copyright 2003 John Wiley & Sons, Ltd.
BACKGROUND: We determined fetal sex in pregnancies referred for invasive prenatal diagnosis procedures by analysis of DNA in maternal plasma. METHODS: Twelve pregnancies at risk of X-linked haemophilia and 32 pregnancies at risk of chromosomal aneuploidies at a gestational age ranging from 10 to 18 weeks recruited before chorionic villus sampling or amniocentesis were involved in the study. Male fetal DNA in maternal plasma was detected by using real-time polymerase chain reaction with the SRY gene as a marker. RESULTS: The specificity of the system reached 100% (no Y signal was detected in 17 women pregnant with a female fetus) and the sensitivity reached 100% (SRY amplification in 27 examined samples). CONCLUSIONS: Amplification of free fetal DNA in maternal plasma is a valid and rapid technique for predicting fetal sex in first- and second-trimester pregnancies and could allow the restriction of invasive sampling procedures to male fetuses at risk of X-linked disorders. Copyright 2003 John Wiley & Sons, Ltd.
Authors: N C P Cross; H E White; D Colomer; H Ehrencrona; L Foroni; E Gottardi; T Lange; T Lion; K Machova Polakova; S Dulucq; G Martinelli; E Oppliger Leibundgut; N Pallisgaard; G Barbany; T Sacha; R Talmaci; B Izzo; G Saglio; F Pane; M C Müller; A Hochhaus Journal: Leukemia Date: 2015-02-05 Impact factor: 11.528
Authors: Elizabeth Schaeffer; Bruno López-Bayghen; Adina Neumann; Leonardo M Porchia; Rafael Camacho; Efraín Garrido; Rocío Gómez; Felipe Camargo; Esther López-Bayghen Journal: Biomed Res Int Date: 2017-06-22 Impact factor: 3.411
Authors: Ana Bustamante-Aragones; Elena Vallespin; Marta Rodriguez de Alba; Maria Jose Trujillo-Tiebas; Cristina Gonzalez-Gonzalez; Dan Diego-Alvarez; Rosa Riveiro-Alvarez; Isabel Lorda-Sanchez; Carmen Ayuso; Carmen Ramos Journal: Mol Vis Date: 2008-08-04 Impact factor: 2.367